GO
Loading...

Acquisitions

More

  • BANGKOK, April 23- PTT Exploration and Production Pcl, Thailand's top oil and gas explorer, has bought Hess Corp's assets in Thailand in a $1 billion deal as part of its attempt to boost its gas business, the company's CEO said on Wednesday.

  • Goldman buys Westpeak in drive for 'smart beta' assets Tuesday, 22 Apr 2014 | 5:15 PM ET

    NEW YORK, April 22- Goldman Sachs Group Inc's asset-management business has agreed to buy Westpeak Global Advisors, a firm that aims to beat market indexes by using factors other than company size to pick stock investments.

  • Einhorn's new course     Tuesday, 22 Apr 2014 | 2:31 PM ET

    Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.

  • *Novartis to buy GSK's oncology assets for $14.5 bln. The deals, which include Novartis buying GSK's cancer drugs and GSK acquiring Novartis' vaccines business, came hot on the heels of a newspaper report that AstraZeneca had turned down a $101 billion bid approach from Pfizer- a story that sent shares across the sector surging.

  • April 22- Canada's Valeant Pharmaceuticals International Inc said on Tuesday it has offered to buy Botox maker Allergan Inc for roughly $47 billion in a move to expand its skin and eye-care portfolio. Bill Ackman's Pershing Square, Allergan's largest shareholder with a 9.7 percent stake, disclosed in a filing on Monday that it is supporting the bid.

  • Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.

  • GlaxoSmithKline CEO Sir Andrew Witty, explains the large portfolio of vaccinations his company provides, and the value added from the company's acquisition of Novartis' vaccination business.

  • Novartis acquisition adds 'tremendous value'     Tuesday, 22 Apr 2014 | 6:45 AM ET

    GlaxoSmithKline CEO Sir Andrew Witty, discusses the benefit to shareholders from his company's acquisition of Novartis' vaccination business, as well as its oncology unit.

  • ZURICH, April 22- Swiss drugmaker Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly in deals worth billions of dollars. Novartis said it had agreed to acquire GSK's oncology products for a $14.5 billion payment.

  • AstraZeneca cancer pipeline likely draw for Pfizer Monday, 21 Apr 2014 | 6:16 PM ET
    A Pfizer technician as she works at Neusentis Ltd.'s research laboratory, a unit of Pfizer Inc., in Cambridge, U.K., on Thursday, Sept. 26, 2013.

    Pfizer Inc may come back to bid for British drug company AstraZeneca Plc after its reported 60 billion pound takeover approach was rejected.

  • BOSTON/ NEW YORK, April 21- Activist investor William Ackman has acquired a nearly 10 percent stake in wrinkle-treatment maker Allergan Inc and is working with Valeant Pharmaceuticals International Inc to buy the company, sources said on Monday.

  • TORONTO, April 21- Talks between Barrick Gold Corp and Newmont Mining Corp about a potential merger have hit a snag, but sources close to the situation say the companies remain keen to reach a deal and discussions are likely to resume.

  • AstraZeneca cancer pipeline seen as draw for Pfizer Monday, 21 Apr 2014 | 6:55 AM ET

    LONDON, April 21- Pfizer may come back to bid for British drug company AstraZeneca after its reported 60 billion pound takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise.

  • TOKYO, April 21- The Bank of Japan is likely to hold off on expanding monetary stimulus for as long as possible but when it does act, it will take "extraordinary" steps such as buying government bonds on a massive scale, a former central bank policymaker said on Monday.

  • April 21- A takeover battle for Canada's Osisko Mining Corp, involving three of the world's top gold producers, is more than just a testament to the quality of the company's low-cost mine, it also spotlights a shortage of top-class gold assets in politically stable areas of the world.

  • LONDON, April 20- U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound takeover, Britain's Sunday Times reported.

  • Comcast in talks with Charter over divestitures -source Saturday, 19 Apr 2014 | 12:05 PM ET

    April 19- Comcast Corp is in talks with Charter Communications over selling or spinning off roughly 3 million subscribers worth approximately $18 billion to $20 billion as part of the divestitures related to its $45.3 billion takeover of Time Warner Cable, according to a source familiar with the matter.

  • April 18- Telus Corp, one of Canada's dominant telecom providers, has reached a new agreement to acquire struggling wireless startup Mobilicity, in a renewed bid to overcome government objections on competition grounds.

  • Facing FTC action, U.S. ringmakers call off deal Thursday, 17 Apr 2014 | 6:53 PM ET

    WASHINGTON, April 17- Jostens, a leader in the school ring and academic memento market, on Thursday said it had dropped plans to acquire competitor American Achievement Corp- a deal the Federal Trade Commission had said it would fight.

  • April 17- Chemicals maker DuPont reported a 57 percent fall in first-quarter net income due to the sale of its performance coating business, which added almost $2 billion to earnings in the year-earlier quarter.